Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
LEVOFLOXACINA ARENA 250 mg
Fluoroquinolone antibiotic, indicated in respiratory and urinary tract infections
Active Substance (INN)
LEVOFLOXACINUM
Packaging
1 blister x 5 FCT 1 blister x 10 FCT
Adverse Reaction Reporting
If you wish to report adverse reactions, please send us the completed adverse reaction reporting form.
Adverse Reaction Form
Read the instructions for use carefully! Consult a doctor or pharmacist to find out about the risks and side effects.